Filgrastim Withdrawn Phase 2 Trials for Leukemias Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00446173Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia